Repare Therapeutics Inc. (RPTX) Tops Q2 EPS by 53c

Repare Therapeutics Inc. (NASDAQ: RPTX) reported Q2 EPS of ($0.28), $0.53 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $30.25 million versus the consensus estimate of $7.01 million.

For earnings history and earnings-related data on Repare Therapeutics Inc. (RPTX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22